Market revenue in 2022 | USD 1,220.7 million |
Market revenue in 2030 | USD 2,513.6 million |
Growth rate | 9.4% (CAGR from 2022 to 2030) |
Largest segment | 13-24 weeks |
Fastest growing segment | 0-12 weeks |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 0-12 weeks, 13-24 weeks, 25-36 weeks |
Key market players worldwide | CooperSurgical, Natera Inc, Eurofins Scientific SE, Illumina Inc, Centogene NV Ordinary Shares, MedGenome, Myriad Genetics Inc, Roche Holding AG, Qiagen NV, Labcorp Holdings Inc, Quest Diagnostics Inc, Biora Therapeutics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non invasive prenatal testing market will help companies and investors design strategic landscapes.
13-24 weeks was the largest segment with a revenue share of 51.72% in 2022. Horizon Databook has segmented the Europe non invasive prenatal testing market based on 0-12 weeks, 13-24 weeks, 25-36 weeks covering the revenue growth of each sub-segment from 2018 to 2030.
Initiatives to improve pricing policies and innovation in this field may revive the already matured Europe non-invasive prenatal testing market, which may boost the market over the forecast period. The percentage of women who undergo NIPT in Germany is more than the European average, which is more than 50%.
Moreover, liberal regulations in several countries for aneuploidy screening are expected to drive market growth. Tissue matching through HLA typing is also allowed in France. However, sex selection of embryos is allowed for medical purposes only.
In addition, Assisted Reproductive Technology (ART) is allowed to be performed only for heterosexual couples if they are married for at least two years before the procedure is performed. Moreover, since NIPT was introduced in the region in 2011, it has gained popularity quickly and companies are forming partnerships and collaborations to explore the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe non invasive prenatal testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe non invasive prenatal testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account